logo

Teva Pharmaceutical Industries Limited (TEVA)



Trade TEVA now with
  Date
  Headline
10/11/2018 5:01:13 AM Teva Draws On Patient Experience To Empower Those Living With Chronic Conditions
10/10/2018 11:02:50 AM Teva Presents 25-year Safety Data From Longest Continuous Trial Of COPAXONE For Treatment Of RMS
10/9/2018 9:02:58 AM Celmatix Enters Partnership To Bring The Fertilome Genetic Test To Israel
10/8/2018 7:02:54 AM Teva To Present New Data At 34th European Committee For Treatment And Research In Multiple Sclerosis Congress In Berlin
9/18/2018 7:02:07 AM Teva Reports Early Results Of Debt Tender Offer And Election Of Early Settlement
9/6/2018 1:22:58 AM Teva Announces Series Of Partnerships And Initiatives In Europe
9/5/2018 9:48:25 AM Teva Appoints John Nason President, TAPI And Biologics Operations
9/4/2018 1:30:53 PM Teva Announces $400 Mln Debt Tender Offer
8/16/2018 7:02:28 AM Regeneron, Teva Unveil Positive Topline Phase 3 Fasinumab Results In Patients With Chronic Pain From OA Of Knee/Hip
8/6/2018 8:02:24 AM Teva Says FDA Approved GRANIX Injection For New Vial Presentation And Indication In Pediatric Patients 1 Month And Older
8/2/2018 7:17:51 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 EPS Estimate To 2.55 - 2.80 From 2.40 - 2.65